Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer

Abstract Introduction Cabazitaxel multiple rechallenges may be a treatment option in heavily pretreated patients with metastatic castration‐resistant prostate cancer (mCRPC) who had a good initial response to cabazitaxel and who are still fit to receive it. Our objective was to assess the efficacy a...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Cedric Pobel, Edouard Auclin, Diego Teyssonneau, Brigitte Laguerre, Mathilde Cancel, Elouen Boughalem, Johanna Noel, Pierre Emmanuel Brachet, Denis Maillet, Philippe Barthelemy, Carole Helissey, Constance Thibault, Stéphane Oudard
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2021-09-01
Cyfres:	Cancer Medicine
Pynciau:	prostate cancer chemotherapy metastasis cancer management urological oncology
Mynediad Ar-lein:	https://doi.org/10.1002/cam4.4172
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!